AVATAN Eye drops

Therapeutic Class

Antiglaucoma Preparation


Avatan Eye Drops is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of or insufficiently responsive to another intraocular pressure lowering medication, as monotherapy or as adjunctive therapy.

Chemical Composition

Each ml contains Travoprost USP 0.04 mg.


Each plastic dropper bottle contains 3 ml sterile eye drops.

Dosage & Administration

The recommended dose is one drops of Avatan in the conjunctival sac of the affected eye (s) once daily in the evening, If more than one topical ophthalmic product is being used, the medicines must be administered at least 5 minutes apart. When substituting another ophthalmic antiglaucoma agent with Avatan, discontinue the other agent and start the following day with Avatan.


Travoprost eye drops is contraindicated in patients with hypersensitive to travoprost or any excipients of this preparation.

Side Effects

The most frequently reported treatment-related side-effect is ocular hyperaemia.